Iterum Therapeutics plc financial data

Symbol
ITRM on Nasdaq
Location
3 Dublin Landings, North Wall Quay, Dublin 1, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Iterum Therapeutics Ltd (to 5/1/2018)
Latest financial report
10-K - Q4 2024 - Feb 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % -69.7%
Debt-to-equity -389 % -159%
Return On Equity 304 %
Return On Assets -105 % -19.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34.6M shares
Entity Public Float 19.2M USD +40.1%
Common Stock, Value, Issued 315K USD +133%
Weighted Average Number of Shares Outstanding, Basic 19.7M shares +52%
Weighted Average Number of Shares Outstanding, Diluted 19.7M shares +52%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 10.5M USD -73.9%
General and Administrative Expense 7.98M USD +6.8%
Operating Income (Loss) -18.7M USD +60.6%
Nonoperating Income (Expense) -5.84M USD -160%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24.5M USD +35%
Income Tax Expense (Benefit) 240K USD -60.8%
Net Income (Loss) Attributable to Parent -24.8M USD +35.4%
Earnings Per Share, Basic -1.26 USD/shares +57.4%
Earnings Per Share, Diluted -1.26 USD/shares +57.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.1M USD +297%
Inventory, Net 0 USD
Assets, Current 24.8M USD -3.16%
Property, Plant and Equipment, Net 23K USD -54.9%
Operating Lease, Right-of-Use Asset 65K USD -88.2%
Intangible Assets, Net (Excluding Goodwill) 19.7M USD
Other Assets, Noncurrent 407K USD -83.1%
Assets 44.6M USD +69.8%
Accounts Payable, Current 251K USD -95%
Employee-related Liabilities, Current 1.14M USD -58.5%
Accrued Liabilities, Current 2.65M USD -65.8%
Liabilities, Current 17.6M USD +30.2%
Operating Lease, Liability, Noncurrent 16K USD -98.6%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 48.7M USD +49%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -486M USD -5.37%
Stockholders' Equity Attributable to Parent -4.08M USD +36.3%
Liabilities and Equity 44.6M USD +69.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD -36.4%
Net Cash Provided by (Used in) Financing Activities 7.22M USD +2971%
Net Cash Provided by (Used in) Investing Activities 7.21M USD +41.2%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 31.5M shares +134%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.32M USD
Deferred Tax Assets, Valuation Allowance 44.6M USD +6.92%
Operating Lease, Liability 67K USD -87.9%
Depreciation 7K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24.8M USD +34.8%
Lessee, Operating Lease, Liability, to be Paid 68K USD -88.7%
Property, Plant and Equipment, Gross 363K USD -0.82%
Operating Lease, Liability, Current 67K USD -81.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD -95.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 68K USD -83.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -7.75%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -83.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 300K USD -25.2%
Deferred Tax Assets, Operating Loss Carryforwards 44.5M USD +7.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 1.91M USD -5.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 300K USD +4.17%
Operating Lease, Payments 385K USD +8.76%
Amortization of Intangible Assets 429K USD 0%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%